Alexa Prescilla-Ledezma

Prof. Alexa Prescilla-Ledezma

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
LMLissette Retana Moreira
Lissette Retana Moreira
APAlexa Prescilla-Ledezma
Alexa Prescilla-Ledezma
ACAlberto Cornet-Gomez
Alberto Cornet-Gomez
FLFatima Linares
Fatima Linares
AJAna Belén Jódar-Reyes
Ana Belén Jódar-Reyes
AOAntonio Osuna
Antonio Osuna
Extracellular vesicles (EVs) are small lipid vesicles released by either any prokaryotic or eukaryotic cell, or both, with a biological role in cell-to-cell communication. In this work, we characterize the proteomes and nanomechanical properties of EVs released by tissue-culture cell-derived trypomastigotes (mammalian infective stage; (TCT)) and epimastigotes (insect stage; (E)) of Trypanosoma cruzi, the etiologic agent of Chagas disease. EVs of each stage were isolated by differential centrifugation and analyzed using liquid chromatography with tandem mass spectrometry (LC-MS/MS), dynamic light scattering (DLS), nanoparticle tracking analysis (NTA), electron microscopy and atomic force microscopy (AFM). Measurements of zeta-potential were also included. Results show marked differences in the surface molecular cargos of EVs between both stages, with a noteworthy expansion of all groups of trans-sialidase proteins in trypomastigote’s EVs. In contrast, chromosomal locations of trans-sialidases of EVs of epimastigotes were dramatically reduced and restricted to subtelomeric regions, indicating a possible regulatable expression of these proteins between both stages of the parasite. Regarding mechanical properties, EVs of trypomastigotes showed higher adhesion compared to the EVs of epimastigotes. These findings demonstrate the remarkable surface remodeling throughout the life cycle of T. cruzi, which shapes the physicochemical composition of the extracellular vesicles and could have an impact in the ability of these vesicles to participate in cell communication in completely different niches of infection.

21 February 2020 in Pathogens
Verified
Journal Article
Open access
PDF file
LMLissette Retana Moreira
Lissette Retana Moreira
DRDaniel Vargas Ramírez
Daniel Vargas Ramírez
FLFatima Linares
Fatima Linares
APAlexa Prescilla-Ledezma
Alexa Prescilla-Ledezma
AGAnnette Vaglio Garro
Annette Vaglio Garro
EAElizabeth Abrahams-Sandí
Elizabeth Abrahams-Sandí
Acanthamoeba is a genus of free-living amoebae widely distributed in nature, associated with the development of encephalitis and keratitis. Despite the fact that it is common to find genotype T5 in environmental samples, only a few cases have been associated with clinical cases in humans. The wide distribution of Acanthamoeba, the characteristic of being amphizoic and the severity of the disease motivate researchers to focus on the isolation of these organisms, but also in demonstrating direct and indirect factors that could indicate a possible pathogenic potential. Here, we performed the characterization of the pathogenic potential of an Acanthamoeba T5 isolate collected from a water source in a hospital. Osmo- and thermotolerance, the secretion of proteases and the effect of trophozoites over cell monolayers were analyzed by different methodologies. Additionally, we confirm the secretion of extracellular vesicles (EVs) of this isolate incubated at two different temperatures, and the presence of serine and cysteine proteases in these vesicles. Finally, using atomic force microscopy, we determined some nanomechanical properties of the secreted vesicles and found a higher value of adhesion in the EVs obtained at 37 °C, which could have implications in the parasite´s survival and damaging potential in two different biological environments.

Verified
Journal Article
Open access
PDF file
APAlexa Prescilla-Ledezma
Alexa Prescilla-Ledezma
FLFatima Linares
Fatima Linares
MOMariano Ortega-Muñoz
Mariano Ortega-Muñoz
LMLissette Retana Moreira
Lissette Retana Moreira
AJAna Belén Jódar-Reyes
Ana Belén Jódar-Reyes
AOAntonio Osuna
Antonio Osuna
Trans-sialidases (TS) are important constitutive macromolecules of the secretome present on the surface of Trypanosoma cruzi (T. cruzi) that play a central role as a virulence factor in Chagas disease. These enzymes have been related to infectivity, escape from immune surveillance and pathogenesis exhibited by this protozoan parasite. In this work, atomic force microscopy (AFM)-based single molecule-force spectroscopy is implemented as a suitable technique for the detection and location of functional TS on the surface of extracellular vesicles (EVs) released by tissue-culture cell-derived trypomastigotes (Ex-TcT). For that purpose, AFM cantilevers with functionalized tips bearing the anti-TS monoclonal antibody mAb 39 as a sense biomolecule are engineered using a covalent chemical ligation based on vinyl sulfonate click chemistry; a reliable, simple and efficient methodology for the molecular recognition of TS using the antibody-antigen interaction. Measurements of the breakdown forces between anti-TS mAb 39 antibodies and EVs performed to elucidate adhesion and forces involved in the recognition events demonstrate that EVs isolated from tissue-culture cell-derived trypomastigotes of T. cruzi are enriched in TS. Additionally, a mapping of the TS binding sites with submicrometer-scale resolution is provided. This work represents the first AFM-based molecular recognition study of Ex-TcT using an antibody-tethered AFM probe.

12 November 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
APAlexa Prescilla-Ledezma
Alexa Prescilla-Ledezma
RBRoberto Blandon
Roberto Blandon
ASAlejandro G. Schijman
Alejandro G. Schijman
ABAlejandro Benatar
Alejandro Benatar
ASAzael Saldaña
Azael Saldaña
AOAntonio Osuna
Antonio Osuna
Background: Trypanosoma cruzi, the hemoparasite that causes Chagas disease, is divided into six Discrete Typing Units or DTUs: TcI-TcVI plus Tcbat. This genetic diversity is based on ecobiological and clinical characteristics associated with particular populations of the parasite. The main objective of this study was the identification of DTUs in patients with chronic chagasic infections from a mountainous rural community in the eastern region of Panama. Methods: A total of 106 patients were tested for Chagas disease with three serological tests (ELISA, rapid test, and Western blot). Molecular diagnosis and DTU typing were carried out by conventional PCRs and qPCR targeting different genomic markers, respectively. As a control sample for the typing, 28 patients suspected to be chagasic from the metropolitan area of Panama City were included. Results: Results showed a positivity in the evaluated patients of 42.3% (33/78); high compared to other endemic regions in the country. In the control group, 20/28 (71.43%) patients presented positive serology. The typing of samples from rural patients showed that 78.78% (26/33) corresponded to TcI, while 9.09% (3/33) were mixed infections (TcI plus TcII/V/VI). Seventy-five percent (15/20) of the patients in the control group presented TcI, and in five samples it was not possible to typify the T. cruzi genotype involved. Conclusions: These results confirm that TcI is the main DTU of T. cruzi present in chronic chagasic patients from Panama. However, the circulation of other genotypes (TcII/V/VI) in this country is described for the first time. The eco-epidemiological characteristics that condition the circulation of TcII/V/VI, as well as the immune and clinical impact of mixed infections in this remote mountainous region should be investigated, which will help local action programs in the surveillance, prevention, and management of Chagas disease.

8 April 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
APAlexa Prescilla-Ledezma
Alexa Prescilla-Ledezma
RBRoberto Blandon
Roberto Blandon
ASAlejandro G. Schijman
Alejandro G. Schijman
ABAlejandro Benatar
Alejandro Benatar
ASAzael Saldaña
Azael Saldaña
AOAntonio Osuna
Antonio Osuna
[This corrects the article DOI: 10.1371/journal.pone.0241921.].

20 November 2024 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
NLNoelia Lozano
Noelia Lozano
APAlexa Prescilla-Ledezma
Alexa Prescilla-Ledezma
ECEva Calabuig
Eva Calabuig
MTMaria Trelis
Maria Trelis
JAJosé Miguel Sahuquillo Arce
José Miguel Sahuquillo Arce
AOAntonio Osuna
Antonio Osuna
Chagas disease, once restricted mainly to the Americas, Chagas disease has become a global health problem due to migration from endemic to non-endemic areas. In non-endemic regions, transmission is limited to vertical transmission from infected mothers to newborns or through blood and organ donations. A major challenge in the management of the disease lies in the diagnosis of chronic cases, as blood-borne parasites are often absent and antibodies persist for life, complicating the evaluation of treatment. This study investigates whether detection of circulating extracellular vesicles (EVs) or their immunocomplexes with host IgGs in the serum of chronic patients with Chagas disease could serve as diagnostic tools and biomarkers of the active presence of the parasite. This method may prove valuable in cases where parasitaemia and other diagnostic tests are inconclusive, especially for assessing treatment efficacy and confirming mother-to-child transmission. Together with exovesicle purification by ultracentrifugation, which is the ‘gold standard’, an affordable and simplified method for the isolation of EVs or immunocomplexes was tested for use in less well-equipped diagnostic laboratories. EV detection was performed by enzyme-linked immunosorbent assay (ELISA) targeting Trypanosoma cruzi antigens. Positive results were demonstrated in Bolivian patients in Spain, covering asymptomatic and symptomatic cases (cardiac, gastrointestinal or both). The study also examined infected mothers and their newborns. These findings were further confirmed in Panamanian patients with inconclusive diagnostic results. Moreover, host IgG isotypes that formed immunocomplexes with parasite exovsicles were identified, with IgG2 and IgG4 being predominant. Our results confirm the usefulness of circulating EVs and their immunocomplexes as markers of metabolically active T. cruzi in chronic infections without detectable parasitaemia, as well as their efficacy in confirming vertical transmission and in cases of inconclusive diagnostic tests. Chagas disease (CD), or American trypanosomiasis, is considered by the WHO as one of the most important neglected diseases of the American continent, considered as strictly American, there are currently cases of the disease spread all over the world as a consequence of human movements even in areas where the biological cycle of the protozoan parasite responsible for the disease does not occur. Laboratory diagnostic methods vary between direct tests that denote active parasitemia in blood in the acute phase of the disease and indirect molecular methods applied when the circulating parasitemia disappears in the chronic phase of the disease. Despite the existence of numerous diagnostic, molecular or immunological tests, the latter being generally easier to perform in diagnostic laboratories, the presence of the parasite always remains in doubt in various situations. Particularly in those patients after treatment since the presence of antibodies to the parasite remain at high titres for years, or in the case of newborn diagnosis in which the mother’s IgG makes specific immunological tests impossible for months. Therefore, given the need to find biomarkers in chronically ill patients or in mothers and newborns that indicate the active presence of parasites, we have used the purification of parasite extracellular vesicles (EVs) in circulating blood or the immunocomplexes they form with host IgGs, by means of two techniques, the gold standard technique by ultracentrifugation and an adapted technique, easier to apply in diagnostic laboratories, to purify these EVs in order to study the recognition of these EVs by antibodies against the parasite or against specific antigens of Trypanosoma cruzi specific antigens. We believe that this technique can be used when it is necessary to evaluate the efficacy of treatments or in neonatal diagnosis.